Page 19 - 《中国药房》2025年10期

MLN/MLNMattersArticles/Downloads/SE0441.pdf. practice models and opportunities for pharmacists[J]. J
[ 8 ] American Pharmacists Association. Billing primer A phar‐ Pharm Pract，2020，33（5）：666-681.
macist’s guide to outpatient fee-for-service billing[EB/ [20] MOFFATT E K，WARGO R，JOHNSON C，et al. Com‐
OL].（2019-08-01）[2025-01-02].https：//www.pharmacist. parative performance of annual wellness visits between
com/Practice/Practice-Resources/Billing-Payment-Center. pharmacists and physicians at primary care clinics[J]. J
[ 9 ] American Pharmacists Association. Delivering medication Am Coll Clin Pharm，2021，4（12）：1524-1533.
therapy management services[EB/OL].（2024-07-03）[2025- [21] ALHOSSAN A，KENNEDY A，LEAL S. Outcomes of an‐
01-02].https：//www.pharmacist.com/Education/Certificate- nual wellness visits provided by pharmacists in an ac‐
Training-Programs/Medication-Therapy-Management. countable care organization associated with a federally
[10] FERRIES E，DYE J T，HALL B，et al. Comparison of qualified health center[J]. Am J Health Syst Pharm，2016，
medication therapy management services and their effects 73（4）：225-228.
on health care utilization and medication adherence[J]. J [22] Centers for Disease Control and Prevention. Approaches
Manag Care Spec Pharm，2019，25（6）：688-695. to increasing access to and participation in diabetes self-
[11] Centers for Disease Control and Prevention. Evidence of management education[EB/OL].（2016-09-01）[2025-01-
impact for community pharmacists and medication therapy 02].https：//www.cdc.gov/diabetes/pdfs/programs/stateand-
management[EB/OL].（2023-03-02）[2025-01-02]. https：// local/emerging_practices-increasing_dsme.pdf.
hdsbpc.cdc.gov/s/article/Evidence-of-Impact-for-Community- [23] GAWLIK G，NGUYEN E，ROBINSON R. Exploring bar‐
Pharmacists-and-Medication-Therapy-Management. riers and facilitators to pharmacist-provided diabetes self-
[12] Centers for Disease Control and Prevention. Collaborative management education and support[J]. J Am Pharm Assoc
practice agreements and pharmacists’ patient care services （2003），2023，63（1）：74-79.
[EB/OL].（2013-06-27）[2025-01-02].https：//www.cdc. [24] American Society of Health-System Pharmacists. Alterna‐
gov/dhdsp/pubs/docs/Translational_Tools_Pharmacists.pdf. tives to incident to billing for revenue generation in non-
[13] Centers for Disease Control and Prevention. Evidence of facility ambulatory clinics[EB/OL].（2019-03-01）[2025-
impact for collaborative drug therapy management[EB/ 01-02]. https：//www. ashp. org/-/media/assets/pharmacy-
OL].（2024-11-09）[2025-01-02].https：//hdsbpc.cdc.gov/s/ practice/resource-centers/ambulatory-care/alternatives-to-
article/Evidence-of-Impact-for-Collaborative-Drug-Therapy- incident-to-billing-2019.ashx?la=en&hash=0A941EB2C-
Management. 12D4474005A59AB3A12E800C98BB5F9.
[14] American Society of Health-System Pharmacists. Billing [25] VASCIMINI A，SABA Y，BASKHAROUN F，et al.
for transitional care management services[EB/OL].（2018- Pharmacist-driven continuous glucose monitoring in com‐
06-01）[2025-01-02].https：//www.ashp.org/-/media/assets/ munity and ambulatory care pharmacy practice：a scoping
pharmacy-practice/resource-centers/ambulatory-care/tran- review[J]. J Am Pharm Assoc（2003），2023，63（6）：1660-
sitional-care-management-codes.ashx?la=en&hash=668D50- 1668.
A1EC1C57494BF81333FB63402A5C12A325. [26] KLEPSER M E，ADAMS A J，SRNIS P，et al. U.S. com‐
[15] MERCURO N J，MEDLER C J，KENNEY R M，et al. munity pharmacies as CLIA-waived facilities：prevalence，
Pharmacist-driven transitions of care practice model for dispersion，and impact on patient access to testing[J]. Res
prescribing oral antimicrobials at hospital discharge[J]. Social Adm Pharm，2016，12（4）：614-621.
JAMA Netw Open，2022，5（5）：e2211331. [27] HOOVER N D，BRIGG TURNER R，SAMPSON J，et al.
[16] American Society of Health-System Pharmacists. FAQ： Financial sustainability of an Oregon rural health，primary
chronic care management and principal care management care，and pharmacist-run comprehensive medication mana-
[EB/OL].（2024-10-01）[2025-01-02].https：//www.ashp. gement program through direct medical billing[J]. J Manag
org/-/media/assets/pharmacy-practice/resource-centers/ Care Spec Pharm，2020，26（1）：30-34.
ambulatory-care/chronic-care-management-faq.ashx. [28] 闫婷，伍琳，熊抚辰，等. 医疗机构药学服务收费政策落
[17] MCCARTHY C，THOMAS BATEMAN M Jr. Impact of 地的关键挑战及优化策略[J]. 卫生经济研究，2025，42
pharmacist-led chronic disease management in a Federally （3）：51-54，58.
Qualified Health Center[J]. J Am Coll Clin Pharm，2022，5 [29] 杜姗，李晋奇，杨勇，等. 我国药学服务收费探索与现状
（12）：1263-1277. 分析[J]. 医药导报，2024，43（9）：1398-1404.
[18] MARTIN R，TRAM K，LE L，et al. Financial performance [30] 钟安妮，罗俊，蒋文硕，等. 全国新增和（或）修订药学服
and reimbursement of pharmacist-led chronic care mana- 务收费项目分析与研究[J]. 临床药物治疗杂志，2025，23
gement[J]. Am J Health Syst Pharm，2020，77（23）：1973- （2）：45-52.
1979. （收稿日期：2024-12-06 修回日期：2025-04-02）
[19] HOHMANN L A，HASTINGS T J，QIAN J J，et al. Medi‐ （编辑：舒安琴）
care annual wellness visits：a scoping review of current

中国药房 2025年第36卷第10期 China Pharmacy 2025 Vol. 36 No. 10 · 1165 ·